InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Shao Weihui, Executive. Director active across 1 company, notably Genscript Biotech Corporation. In total, 3 disclosures have been logged. Activity tracked since 2 April 2026. The latest transaction was filed on 8 June 2026 (Sale). Regulator: HKEX. The full history is free.
3 of 3 declarations
Shao Weihui is an executive at Genscript Biotech Corporation. He is involved in managing operations and the strategic development of the company, which focuses on biotechnology. His role is essential for innovation and growth.